Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon-based PCIA for Pain Management After Laparoscopic Surgery
NCT07525986Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2026
- Primary completion
- Mar 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hsk21542 in Visceral pain, postoperative pain, sponsored by Peking University First Hospital. Started Apr 2026; status: recruiting.
02
Drugs
hsk21542
03
Conditions
Visceral painpostoperative pain
Beyond the preview
Go deeper on NCT07525986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07525986.